Table 5 Recommendations on the CD4 cell count, HIV viral monitoring, and other tests
From: Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand
Laboratory testing | At entry into care | First year of ART | After first year |
|---|---|---|---|
CD4 cell count | At entry | At 6 and 12 months | At 6 and 12 months until CD4 count > 350 cells/mm3 with viral load <50 copies/ml and once a year afterward. |
Plasma HIV viral load | - | At 3 and 6 months | Every 12 months if viral load <50 copies/ml |
HBsAg | At entry | - | - |
Anti-HCV | At entry | - | - |
VDRL | At entry | - | - |
ALT | At entry | If indicated | At entry |
Creatinine | At entry | At 6 and 12 months | Every 12 months or if indicated |
Total cholesterol | High risk group | Every 12 months or if indicated | Every 12 months or if indicated |
Fasting blood sugar | High risk group | Every 12 months or if indicated | Every 12 months or if indicated |
Urinalysis | At entry | Every 12 months or if indicated | Every 12 months or if indicated |